Background: The intake of leptin during the suckling period protects against obesity and improves insulin and central leptin sensitivity in adult rats. Objective: We analyzed whether leptin treatment to neonates may also improve later peripheral leptin sensitivity in adipose tissue under high-fat (HF) diet conditions. Design: Male rats were supplemented with a daily oral dose of leptin or the vehicle (controls) during the suckling period. After weaning, animals were fed a normal-fat or an HF diet until the age of 6 months. At this age, mRNA and protein levels of the longform leptin receptor (OB-Rb) and the expression of other genes related with energy metabolism were measured in various adipose depots (inguinal, mesenteric and retroperitoneal). Results: HF-diet feeding resulted in lower OB-Rb mRNA and protein levels in internal depots in controls but not in leptin-treated animals; these animals maintained OB-Rb mRNA and protein levels under HF-diet conditions in these depots, particularly in the mesenteric one, and this was accompanied by increased expression of genes related with energy uptake (GLUT4, CD36), fatty acid oxidation (peroxisome proliferator activated receptor-a (PPARa), CPT1, UCP3) and lipogenesis (PPARg, GPAT). Leptintreatment also ameliorated HF-diet-induced hepatic fat accumulation occurring in control animals. Conclusion: Leptin treatment during the suckling period may improve the lasting effects of HF-diet feeding on leptin receptor abundance in the adipose tissue and increase its oxidative capacity, resulting in a better handling and partitioning of excess fuel. This, together with the described improvement of central leptin sensitivity, may explain why these animals are more protected against diet-induced obesity and its metabolic-related disorders.
Introduction
Leptin is one of the main hormones involved in the regulation of energy balance. 1 Its circulating levels depend predominantly on its secretion by adipose tissue and are proportional to the size of the adipose tissue and the nutritional status. 2, 3 Leptin exerts its effects by binding to its specific receptors (OB-R) located in several tissues throughout the body. Leptin receptors are members of the cytokine receptor class I 4 and are produced in several alternatively spliced forms. 5 The longer form of the leptin receptor (OB-Rb) is primarily expressed in distinct nuclei of the hypothalamus and is considered to be the signalingcompetent isoform. 6 This receptor mediates most of the effects of leptin through JAK/STAT signaling pathway. 7 Although most of the actions of leptin have been related to the activation of its receptor in the central nervous system, leptin may also function as an autocrine and paracrine factor exerting direct physiological effects, independently of the central nervous system, 8 in accordance with an almost ubiquitous distribution of its receptor. 3 In fact, the role of leptin in the adipose tissue has been reported to be essential regulating adipocyte metabolism. 9, 10 Its importance has been reinforced by studies of adipocyte-specific reduction of the expression of the leptin receptor in mice by antisense RNA. 11 These mice showed an obese phenotype, with increased adiposity, dyslipidemia and insulin resistance, 11 suggesting that the peripheral actions of leptin may also help regulate the entire body weight and metabolism. Moreover, it has been described that diet-induced obesity in rats produces downregulation of the OB-Rb expression in adipose tissue, producing a leptinergic blockade at peripheral level. 12 The same authors also described the prevention of diet-induced obesity in transgenic mice constitutively expressing OB-Rb. 12 All in all, these results provide evidence of the important role of the peripheral leptin system in adipocyte lipid metabolism and in the development of obesity and its metabolic associated disorders. Besides the role of leptin in the regulation of energy balance, this hormone is essential during the perinatal period for the development of key areas of the hypothalamus involved in the central regulation of energy balance. 13, 14 Variations in both prenatal and postnatal nutritional environments influence the neuronal circuits that control energy metabolism, and, among other metabolic-related hormones, leptin has been proposed to be one of the main signals linking perinatal nutritional environment and energy balance programming. [15] [16] [17] [18] We have described the importance of leptin during the lactation period, in both regulating neonate food intake and affecting the developmental events involved in the control of energy balance in adulthood. 16 During the suckling period, oral leptin can be absorbed by the immature stomach of the neonate 19, 20 and be transferred to the neonatal circulation and exerts its effect as a satiety hormone, thus having a role in the short-term control of food intake. 20 Furthermore, the oral administration of physiological doses of leptin during the suckling period prevents the high-fat (HF)-diet-induced adverse metabolic phenotype and improves insulin and central leptin sensitivity in adulthood. 18, 21 These results suggested that leptin may be involved in early programming mechanisms of food intake and metabolism control systems. 16 These changes seen later in life can be summarized in higher sensitivity to leptin and a lower tendency to have diet-induced leptin resistance, which emphasizes the importance of the proper activity of leptin for body weight and metabolism management. Bearing in mind that the oral intake of leptin during the suckling period may protect from diet-induced central leptin resistance in adulthood, and also considering the putative importance of the peripheral actions of leptin on adipose tissue, in this work we aimed at studying the long-term effects of leptin supplementation during the suckling period on the mRNA and protein levels of the long form of the leptin receptor in adipose tissue of rats under normal-fat (NF) feeding conditions and in response to an HF-diet feeding. In addition, as leptin peripheral actions are involved in the adipocyte lipid metabolism and may be related with body weight control, we also analyzed the expression patterns of metabolism-related genes in the adipose tissue and liver. Given the clinical importance of body fat distribution and also the known differences in the fat-depot metabolic profile, 22, 23 we have analyzed adipose tissue from different anatomical localizations, including internal and subcutaneous depots.
Materials and methods

Animals and experimental design
The study was performed using 30 pups from six different dams, following the same protocol during suckling period as previously described. 18 Briefly, 3-month-old virgin female
Wistar rats were mated with male rats (Charles River Laboratories, Barcelona, Spain). At day 1 after delivery, excess pups in each litter were removed to keep 10 pups per dam, and the male pups were randomly assigned into two groups: control group and leptin-treated group. From day 1 to day 20 of lactation, and during the first 2 h of the beginning of the light cycle, 20 ml of the vehicle (water)F control groupFor a solution of recombinant murine leptin (PeproTech, London, UK) dissolved in waterFleptin-treated groupFwas given orally every day to the pups using a pipette, following the same protocol as described. 18, 21 The amount of leptin given to animals was calculated as five times the average amount of the daily leptin intake from the mother's milk. 20 It was consider that this dose was within the 'physiological' range taking into account the great variation within mothers. On day after weaning, both control and leptin-treated male rats were single-caged and split into two groups, which were fed ad libitum with an NF diet (3.8 kcal g
À1
, with 10% calories from fat) or an HF diet (with 4.7 kcal g
, with 45% calories from fat) (Research Diets Inc., New Brunswick, NJ, USA).
At the age of 6 months, animals were killed by decapitation under fed conditions, during the first 2 h of the beginning of the light cycle. The liver and various white adipose tissue depots (WAT)Fgonadal, retroperitoneal, mesenteric and inguinalFwere rapidly removed. All samples were weighed and immediately frozen in liquid nitrogen and stored at À70 1C. The retroperitoneal and mesenteric depots (as internal) and the inguinal depot (as subcutaneous) were selected as representative to perform mRNA expression and protein analysis. Blood was also collected and centrifuged at 1000 g for 10 min to collect the serum, which was stored at À20 1C until analysis. The animal protocol followed in this study was reviewed and approved by the bioethical committee of our university and guidelines for the use and care of laboratory animals of the university were followed.
Quantification of leptin, insulin and glucose concentration
Leptin concentration was measured with a mouse leptin enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, MN, USA). Serum insulin concentration was measured using an ELISA kit (DRG Instruments, Marburg, Germany). Glucose concentration was measured enzymatically using a commercial kit, following standard procedures (Roche and R-Biopharm, Darmstadt, Germany).
Quantification of serum triacylglyceride and nonesterified (or free) fatty acid concentration and hepatic lipid content Triacylglyceride concentration was measured enzymatically using commercial kits and following standard procedures (Sigma, Madrid, Spain). Nonesterified (or free) fatty acids in serum were measured by an enzymatic colorimetric method using a commercial kit (WAKO NEFA C assay; Wako Chemicals USA Inc., Wako Chemicals, Neuss, Germany).
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Total lipids were extracted from about 600 mg of hepatic tissue and quantified by the method of Folch et al.
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Western blot analysis of OB-Rb levels Various WAT depots (inguinal, retroperitoneal and mesenteric) were homogenized at 4 1C in PBS (1:4, wt/vol). The homogenate was centrifuged at 7000 g for 2 min and the supernatant was used for total protein analysis by Bradford method. 25 The proteins (100 mg) were boiled in Laemmli sample buffer containing 5% 2-mercaptoethanol. After 2 min boiling total protein was fractionated by SDS-polyacrylamide gel electrophoresis (7.5% polyacrylamide) according to Laemmli 26 and electrotransferred onto a nitrocellulose membrane (Bio-Rad, Madrid, Spain). After blocking, the membrane was incubated with the primary rabbit polyclonal anti-rat-OB-Rb antibody mapped to the C-terminal region of the receptor (catalog number ObR13-A, diluted 1:500; Alpha Diagnostic International, San Antonio, TX, USA) and then with the secondary biotinylated anti-rabbit immunoglobulin G antibody conjugated to a streptavidin biotinylated horseradish peroxidase complex (diluted 1:5000; GE Healthcare, Buckinghamshire, UK). The immunocomplexes were revealed using an enhanced chemiluminescence detection system (ECL, GE Healthcare Europe GmbH, Barcelona, Spain). Membranes were exposed to Hyperfilm ECL (GE Healthcare Europe GmbH). The films were scanned and quantified as described before. 0 . Real-time PCR was performed using the Applied Biosystems StepOnePlus Real-Time PCR Systems (Applied Biosystems) with the following profile: 10 min at 95 1C, followed by 40 two-temperature cycles (15 s at 95 1C and 1 min at 60 1C). To verify the purity of the products, we produced a melting curve after each run, according to the manufacturer's instructions, and the size of the amplicon was confirmed by electrophoresis. The threshold cycle (C t ) was calculated by the instrument's software (StepOne software version 2.0) and the relative expression of each mRNA was calculated as a percentage of control rats with the 18 s as reference gene as described before. 18 Statistical analysis Data are expressed as means±s.e.m. (n ¼ 6-8). Two-way analysis of variance (ANOVA) was used to determine the significance of the effect of leptin treatment and diet on the measured parameters. Single differences between NF and HF on control and leptin-treated animals were assessed by Student's t-test. Threshold of significance was defined at Po0.05.
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Results
Effects of HF-diet feeding on body weight, cumulative food intake and different biochemical parameters Table 1 shows the data about body and tissue weights, cumulative food intake, and serum biochemical parameters in control and leptin-treated rats fed with NF or HF diet. As previously described in the same cohort of animals, 18 rats that were treated with physiological doses of leptin during the suckling period present lower body weight and adiposity under both NF-and HF-diet feeding conditions. Leptintreated rats, compared with untreated controls, showed a lower adiposity index (estimated as the sum of the weights of inguinal, mesenteric, retroperitoneal and epididymal WAT, divided by body weight Â 100) and, when comparing depots individually, lower relative weights of the inguinal and mesenteric depots, under both dietary conditions. The weight of the liver decreased in the leptin-treated group feeding with the HF diet compared to their counterparts fed with the NF diet (by Student's t-test). Serum insulin levels increased in both groups of animals as an effect of HF-diet feeding, but the change was not statistically significant (by Student's t-test) in the leptin-treated group. Circulating levels of glucose, leptin, triglycerides and free fatty acids were not significantly changed by effect of diet or treatment. Cumulative food intake from day 21 to 6 months was lower in leptin-treated animals both under NF-and HF-diet feeding
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Effects of HF-diet feeding on hepatic lipid content and on the expression of genes related with fatty acid metabolism High-fat-diet feeding elicited increased hepatic fat accumulation in both control and leptin-treated animals ( Figure 1a ), but this increase was stronger in control animals than in leptin-treated animals (80 vs 38% increase). Moreover, leptin-treated animals presented lower hepatic content of lipids under both feeding conditions (Po0.05 by two-way ANOVA), although differences were more marked under HF-diet feeding conditions. The expression of the fatty acid oxidation-related genes, PPARa and CPT1L, increased as an effect of HF-diet feeding in both groups of animals ( Figure 1b ), but this increase was higher in controls than in leptin-treated animals. The expression levels of PPARa under NF-diet feeding conditions were higher in leptintreated animals than in control. The hepatic expression levels of SCD1 decreased as an effect of HF-diet feeding in both control and leptin-treated animals (Po0.05, two-way ANOVA).
Effects of HF-diet feeding on the mRNA and protein levels of the long form of leptin receptor (OB-Rb) in various WAT depots The mRNA and protein levels of OB-Rb in various WAT depots (inguinal, mesenteric and retroperitoneal) are shown in Figure 2 . In control animals, HF-diet feeding resulted in a decrease in OB-Rb mRNA and protein levels in internal (mesenteric and retroperitoneal) depots, without affecting its mRNA and protein levels in the subcutaneous (inguinal) one. Unlike controls, leptin-treated animals under HF-diet feeding maintained the mRNA and protein levels of OB-Rb in the mesenteric adipose tissue and even showed higher expression levels of this receptor, compared with those animals on NF diet. In the retroperitoneal depot, OB-Rb mRNA levels were maintained unchanged under HF-diet feeding in leptin-treated animals compared with those on NF Leptin in lactation and metabolic adaptations T Priego et al diet, but a decrease in protein abundance was found in both control and leptin-treated rats (Po0.05, two-way ANOVA); however, the control group presented a greater decrease of this receptor (44% decrease) compared with the leptintreated group (30% decrease) and when analyzing separately control and leptin-treated animals, the decrease was only significant in control animals (Po0.05, Student's t-test).
Effects of HF-diet feeding on the expression of genes related with glucose and fatty acid uptake in various WAT depots Figure 3 shows the mRNA expression levels of the GLUT4, the free fatty acid transporter CD36, and LPL in the three adipose depots studied. As a general trend, HF-diet feeding induced a different response in control and leptin-treated animals concerning the expression of these genes.
In the inguinal depot, HF-diet feeding resulted in higher mRNA levels of GLUT4 and of CD36 only in leptin-treated animals, without affecting their expression levels in control animals. A similar tendency, although not statistically significant, was found for LPL mRNA levels. In addition, LPL expression levels were lower in leptin-treated animals compared with controls under NF-diet feeding conditions.
In the mesenteric depot, dietary treatment resulted in lower mRNA levels of GLUT4 in control animals, whereas its Leptin in lactation and metabolic adaptations T Priego et al levels of expression increased in leptin-treated animals on HF-diet feeding. However, under NF-diet conditions, leptintreated animals presented lower GLUT4 expression levels than control animals. CD36 expression levels increased in leptin-treated animals as an effect of HF-diet feeding, whereas no effects were shown in control animals. LPL expression levels remained unchanged in both groups of animals under both dietary conditions. In the retroperitoneal depot, HF-diet feeding differently affected GLUT4, CD36 and LPL expression levels between control and leptin-treated animals: whereas HF-diet feeding resulted in lower (GLUT4) or unchanged (CD36, LPL) mRNA levels of these genes in control animals, their levels increased (GLUT4, CD36) or tended to increase (LPL) in leptin-treated animals. However, under NF-diet feeding conditions, leptintreated animals presented lower expression levels of GLUT4, CD36 and LPL than control animals.
Effects of HF-diet feeding on the expression of genes related with fatty acid oxidation in various WAT depots Figure 4 shows the expression of several genes related with fatty acid oxidation (PPARa, PGC1, CPT1, UCP3) in the three WAT depots studied.
In the inguinal depot, HF-diet feeding resulted in higher expression levels of PPARa, PGC1 and CPT1 compared with controls under NF-diet, in both control and leptin-treated animals. However, in the case of PGC1, statistical significance (by Student's t-test) between HF-and NF-diet fed animals was only found in the leptin-treated group. Concerning UCP3, although both groups of animals under HF-diet feeding showed an increase in UCP3 expression levels compared with controls under NF-diet, the increase was stronger in the leptin-treated animals compared with the control ones (285 vs 68% increase).
In the mesenteric depot, an interaction between diet and treatment was found concerning the expression levels of the different fatty acid oxidation related genes studied: HF-diet feeding decreased the expression levels of PPARa, PGC1 and CPT1 in control animals whereas the levels remained unchanged in leptin-treated animals. In addition, UCP3 mRNA expression levels increased in leptin-treated animals under HF diet but not in control animals. Notably, the expression levels of PPARa, PGC1 and UCP3 were lower in leptin-treated animals compared with the control ones under NF-diet feeding conditions.
In the retroperitoneal depot, PPARa and UCP3 expression levels did not change as an effect of diet or treatment, whereas PGC1 and CPT1 increased in leptin-treated animals as an effect of HF-diet feeding but remained unchanged in control animals.
Effects of HF-diet feeding on the expression of genes related with lipogenesis in various WAT depots
To assess whether leptin treatment during the suckling period affects WAT lipogenesis capacity under HF-diet feeding, the expression levels of the adipogenic factor PPARg and of genes related with the synthesis of fatty acids (FAS, ACC1) and of triacylglycerides (GPAT) were analyzed ( Figure 5 ). In the inguinal depot, HF-diet feeding differentially Leptin in lactation and metabolic adaptations T Priego et al affected the expression levels of PPARg between control and leptin-treated animals: HF-diet feeding resulted in higher expression levels of PPARg in leptin-treated animals whereas no changes were found in control animals. Concerning FAS, HF-diet feeding resulted in lower expression levels of this gene in control animals, compared with those of animals under NF diet, whereas no changes were found in leptintreated animals. Of note, leptin-treated animals presented lower expression levels of this enzyme under NF-diet conditions compared with control animals. HF-diet feeding increased the mRNA levels of GPAT in both groups of animals but this increase was greater and statistically significant in the leptin-treated one (63 vs 127% increase). In the mesenteric depot, an interactive effect between diet and treatment was found about the expression levels of PPARg, FAS and GPAT. HF-diet feeding decreased mRNA levels of PPARg and FAS in control animals whereas the levels remained unchanged in leptin-treated animals. As to GPAT, Leptin in lactation and metabolic adaptations T Priego et al the levels of expression increased under HF-diet conditions only in leptin-treated animals. Moreover, both control and leptin-treated animals showed lower ACC1 mRNA levels under HF diet, about NF-diet conditions, but this decrease was higher in control animals. Under NF-diet feeding conditions leptin-treated animals presented lower mRNA levels of PPARg, FAS and GPAT compared with control animals.
In the retroperitoneal depot, an interaction between diet and treatment was found regarding the expression levels of PPARg, ACC1 and GPAT: the expression levels of these genes were unchanged (PPARg, ACC1) or decreased (GPAT) in control animals as an effect of HF-diet feeding, whereas they increased in leptin-treated ones. HF-diet feeding decreased the expression levels of FAS in both groups of animals. Leptin-treated animals presented lower levels of GPAT than control animals under NF-diet feeding conditions.
Discussion
There is increasing epidemiological and experimental evidence showing that nutritional variables during perinatal life have lasting effects on metabolic phenotype, and some of these factors are major contributors to obesity in later life. 15, 16 In this sense, we have previously shown in rats that the intake of moderate amounts of leptin during the suckling period prevents the development of overweight in later life, 18 and these long-term effects of leptin on body weight control were associated with an increased sensitivity to the central effects of leptin 21 and with a protection against central leptin resistance induced by dietary treatment. 18 Indirect evidence of the role of maternal milk-derived leptin in body weight control of infants has also been found in humans. 17 These results suggest that leptin may be involved in early programming mechanisms in the leptin signaling system. 16 In fact, during the perinatal period, leptin has been shown to be essential for the correct development of the brain, particularly the hypothalamic sites involved in food intake control. 13, 14 Moreover, we show here that leptin during the neonatal period may also program a better response of the adipose tissue to an HF diet, by preventing the decrease of leptin receptor in internal depots and increasing the oxidative capacity of this tissue. Leptin is important in the whole-body metabolism acting in the periphery, especially by regulating glucose and fatty acid metabolism in skeletal muscle and adipose tissue. 8 The role of leptin in adipose tissue has been reported as essential regulating energy storage. 12 Leptin can exert its effect as an autocrine or paracrine signal modulating the rate of synthesis and degradation of lipids. 29, 30 Because adipose tissue is a key organ involved in energy handling and storage, changes at the level of the leptin receptor in adipose tissue can be of great importance in the development of obesity and its related metabolic disorders. In fact, a lower mRNA abundance of OB-Rb in the adipose tissue has been described in humans with morbid obesity 31 and we have previously described that chronic HF-diet feeding results in lower expression levels of OB-Rb in WAT in male but not in female rats. 32 Here, we found that chronic HF-diet feeding resulted in lower OB-Rb mRNA and protein levels in internal (mesenteric and retroperitoneal) adipose depots. OB-Rb levels (at least at the central level) have been associated to the sensitivity to leptin. 6 Interestingly, the animals treated with physiological doses of leptin during the suckling period were apparently protected against this decrease in OB-Rb mRNA and protein levels occurring on HF diet in the mesenteric depot (in fact OB-Rb mRNA levels even increased under these conditions) and in the retroperitoneal depot, although in the latter the protective effect was more clear regarding the expression levels. Altogether, this adaptation may lead to a more adequate response to the dietary stress of HF-diet feeding, in accordance with literature showing that the constitutive adipocyte-specific overexpression of OB-Rb in transgenic mice prevents these animals from obesity development under HF-diet feeding. 12 Thus, it is suggested that the functionality of this receptor at adipose tissue level may be critical for the control of fat reserves. Leptin exerting its effect directly on adipocytes has been shown to reduce triglyceride accumulation in these cells by increasing fatty acid oxidation. 33, 34 In this sense, in the inguinal depot, the only one that maintains the levels of OB-Rb unaltered after HF-diet feeding, we found increased expression levels of several markers of fatty acid oxidation (PPARa, PGC1, CPT1 and UCP3) in both groups of rats under HF-diet feeding. This increase in fatty acid oxidation capacity occurring in the subcutaneous tissue may be of great importance considering that this tissue has a greater oxidative capacity than internal depots, such as the retroperitoneal fat, 35 and thus its contribution may be quantitatively relevant. It is noteworthy the significant increase (285%) in UCP3 mRNA levels occurring in this depot in leptin-treated rats under HF-diet feeding. UCP3 has been proposed to have a primary function in the regulation of the use of lipids as fuel substrate, 36 then the increased transcription of this gene may be indicative of increased fatty acid oxidation. Visceral fat accumulation, more than fat accumulation in subcutaneous regions, has been strongly linked to features of the metabolic syndrome, including leptin and insulin resistance, type 2 diabetes, hypertension and dyslipidemia. 22, 37, 38 In this sense, we found here, as far as the leptin receptor is concerned, that the internal adipose depots were more affected by dietary treatment than the subcutaneous one. OB-Rb mRNA and protein levels decreased in control untreated rats under HF-diet feeding in both internal depots studied. Nevertheless, leptin-treated animals maintained OB-Rb mRNA and protein levels under HF-diet conditions in the mesenteric depot. In this depot, the decrease in the abundance of OB-Rb in HF-diet fed control animals can be associated with the decrease found in the expression of different genes related with fatty acid oxidation (PPARa, Leptin in lactation and metabolic adaptations T Priego et al PGC1, CPT1 and UCP3). However, when the animals were treated with leptin during the suckling period, there was no apparent diet-induced decrease in leptin receptor in this depot, and these animals were also protected against the decrease in the expression levels of fatty acid oxidation-related genes, and even presented increased expression levels of UCP3.
In the retroperitoneal depot, leptin treatment also improved the decrease in the OB-Rb levels in the rats fed with the HF diet. In addition, these rats showed higher expression levels of PGC1 and CPT1 in response to HF-diet feeding. On the whole, these results suggest that leptin-treated rats maintain or even increase fatty acid oxidation capacity in adipose tissue in response to HF-diet feeding, and this may be associated to the maintenance of OB-Rb levels. The increase in fat oxidation capacity may be of great importance for the control of wholebody weight and fat reserves; in this way leptin-treated rats presented lower body weight and adiposity compared with the control rats. However, it must be highlighted that HF feeding resulted in a higher relative increase of some of the adipose tissue depots in leptin-treated animals compared with their control counterparts, being the retroperitoneal depot the one with the highest increase. This could be tentatively explained by a higher efficiency of the adipose tissue of leptin-treated animals sequestering the excess of fuel from the diet, instead of being accumulated in nonadipose tissue depots, such as the liver. This pivotal function of the adipose tissue under conditions of high fat influx has been previously suggested. 39 Leptin resistance in WAT has been associated with insulin resistance and dyslipidemia, 11 in fact this has been proposed to be the major contributing factor to the insulin resistance observed in obese subjects. 11 Our study results support this hypothesis showing that the expression levels of some genes regulated by insulin, such as GLUT4, are downregulated in control animals under HF-diet feeding in the same fat depots (mesenteric and retroperitoneal) in which a decrease in leptin receptor levels is also observed. The expression of other lipogenic genes also regulated by insulin, such as the transcription factor PPARg (which mediates insulin action on GLUT4) or the enzymes FAS, ACC1 and GPAT, 40, 41 which are also downregulated in one or both internal depots studied of control animals under HF-died feeding, could also be associated with peripheral resistance to both leptin and/or insulin. However, in leptin-treated animals, the maintenance of leptin receptor levels was accompanied by higher GLUT4 and GPAT mRNA expression levels in all fat depots studied. As a general trend, these results show that the leptintreated rats respond to HF-diet feeding by increasing glucose and fat uptake capacity by the adipocyte, as well as its storage as triglycerides, whereas this response was not found in control rats, in which no adaptation or even a decrease in the expression levels of some genes involved in substrate uptake and lipogenesis was found, particularly in the internal depots. A higher capacity to channel the energy excess from the diet to the adipose tissue has been related with a better adaptive response to an HF diet 28 and higher sensitivity to insulin. 42 Moreover, the capacity of leptin-treated rats to maintain or even enhance lipogenesis capacity may prevent the accumulation of excess of fat in other organs, such as the liver. Conversely, a lower capacity of uptake and use of excess of fat by the adipose tissue may cause metabolic disturbances, including insulin resistance, due to the deposition of this fat in other tissues such as liver, skeletal muscle and pancreas. 42, 43 In concordance with this, control rats under HF-diet feeding showed higher hepatic lipid content (80% increase compared with those under NF-diet feeding conditions). This was accompanied by an increased expression of fatty acid oxidation related genes (PPARa and CPT1) and a decrease in the expression of the SCD1. SCD1 is the ratelimiting enzyme in the biosynthesis of monounsaturated fatty acids. It is important in the pathophysiology of the fatty liver and in body weight regulation. 44 In addition, leptin participates in the regulation of this enzyme, repressing its gene expression and its enzymatic activity in liver. 45 The fact that the expression levels of this enzyme decrease in both groups of rats may indicate that the liver is not severely affected by the excess of fat coming from the diet and is able to respond to the leptin signaling. However, in leptin-treated rats, a lower deposition of lipids in the liver together with a lower increase in the mRNA levels of PPARa and CPT1 may be indicative of a lower hepatic handling of fuel excess compared with their control counterparts. In this sense, we have previously described that leptin treatment protects the animals from diet-and age-related insulin resistance, 18, 21 and the present results suggest that the prevention of dietinduced decrease of leptin receptor in adipose tissue may be associated with higher insulin sensitivity. Insulin resistance has also been related with visceral fat deposition, 22 and it is interesting to highlight that leptin-treated rats (with improved insulin sensitivity) show lower fat deposition in the mesenteric region under both feeding conditions, compared with control rats. It is noticeable that, under NF-diet feeding conditions, leptin-treated rats showed lower expression levels of some genes related with substrate uptake (GLUT4, LPL), fatty acid oxidation (PPARa, PGC1, UCP3) and lipogenesis (PPARg, FAS, GPAT) in some of the adipose depots studied, compared with untreated control rats. This does not seem to be attributed to lower leptin/insulin sensitivity, but could be attributed to the fact that these animals have a better control of food intake and eat fewer calories, as previously described, 18 with the consecutive decrease in the energy surplus to be stored in adipose tissue; in agreement with the lower body weight and fat content of these animals, compared with their untreated control counterparts. In this sense, it cannot be ruled out that part of the results showed here may be an indirect consequence of the improvement of central leptin sensitivity, with the resulting better control of food intake. Nevertheless, the metabolic response of leptin-treated rats under HF-diet feeding seems to be better despite the increase in body weight, adiposity and calorie intake, suggesting that these animals may be programmed to be more robust to maintain metabolic homeostasis in adult life.
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In addition to the adipose tissue, the skeletal muscle is also a site for leptin action. In fact, a direct effect of leptin in skeletal muscle activating glucose uptake, 46 glucose and lipid oxidation, 47 mitochondrial uncoupling activity and increasing oxygen consumption 48 has been reported, suggesting that this hormone may have a key role in activating muscle energy consumption. 49 Here, we have not focused on the study of the lasting effects of leptin treatment during lactation on skeletal muscle metabolism, although it can be mentioned that, in these conditions, we found no significant changes in OB-Rb mRNA expression levels in the gastrocnemius muscle among the different groups (data not shown). However, this does not preclude the possibility that changes in leptin signaling in skeletal muscle could also contribute to the beneficial and long-lasting effects of the leptin treatment. This is an interesting issue to be addressed.
In conclusion, supplementation with physiological doses of leptin during the suckling period may program a better adaptation to face HF-diet feeding conditions, by preventing the decrease of leptin receptor in internal depots. This may contribute to the improved capacity to control body weight and avoid metabolic disturbances under dietary stressors such as HF-diet feeding. In particular, the protective effect on the adipose tissue leptin system may be associated with a better handling and partitioning of excess fuel, improving the sensitivity of these rats to insulin and preventing other metabolic disorders related with HF-diet feeding, such as hepatic lipid accumulation. All in all, these results help to comprehend the long-term effects of metabolic programming by leptin during lactation, conferring protection against obesity and its metabolic-related disorders in later life, thus highlighting the usefulness of the intake of leptin during the suckling period as an early preventive strategy against these illnesses.
